CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $77M invested in Concert Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
Holders
79
Holding in Top 10
–
Calls
$230K
Puts
$161K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$1.16M | |
| 3 | +$1.16M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$939K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$685K |
Top Sellers
| 1 | -$6.99M | |
| 2 | -$1.72M | |
| 3 | -$1.67M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.39M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$955K |